This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Study on Lixisenatide and Counterregulation to Hyp...
Clinical trial

Study on Lixisenatide and Counterregulation to Hypoglycemia

Read time: 1 mins
Last updated:16th Dec 2013
In hypoglycemia, there is a counterregulation to restore glucose levels. An important part of this counterregulation is the release of the hormone glucagon. Since the GLP-1 receptor agonist lixisenatide has been shown to be associated with a low risk of hypoglycemia, this study examines whether lixisenatide affects the glucagon response to hypoglycemia.
Category Value
Study start date 2013-12-16

View full details